Pharmacogenomic Biomarkers in Neuropsychiatry: The Path to Personalized Medicine in Mental Disorders-Reference-Cited by-同舟云学术

Pharmacogenomic Biomarkers in Neuropsychiatry: The Path to Personalized Medicine in Mental Disorders

Published:2009 Issue: Volume: Page:3-63
ISSN:
Container-title:The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes
language:
Short-container-title:

Author:

Cacabelos Ramón

Publisher

Springer Netherlands

Link

http://link.springer.com/content/pdf/10.1007/978-90-481-2298-1_1

Reference206 articles.

1. Andlin-Sobocki P, Jönsson B, Wittchen H-U, Olesen J. Costs of disorders of the brain in Europe. Executive summary. Eur J Neurol 2005; 12(Suppl 1):x–xi.

2. Cacabelos R. Psychogeriatric research. A conceptual introduction to geriatric neuroscience. Psychogeriatrics 2001; 1:158–188.

3. Loveman E, Green C, Kirby J et al. The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease. Health Technol Assess 2006; 10:1–176.

4. Cacabelos R, Alvarez XA, Lombardi V et al. Pharmacological treatment of Alzheimer disease: from phychotropic drugs and cholinesterase inhibitors to pharmacogenomics. Drugs Today 2000; 36:415–499.

5. Cacabelos R. Pharmacogenomics in Alzheimer's disease. Min Rev Med Chem 2002; 2:59–84.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomics of Alzheimer’s Disease: Novel Strategies for Drug Utilization and Development;Methods in Molecular Biology;2022

2. Pharmacogenetic and Association Studies on the Influence of HLA Alleles and Rivastigmine on the Iranian Patients with Late-Onset Alzheimer’s Disease;Molecular Neurobiology;2021-01-27

3. Pharmacogenetics of Neurodegenerative Disorders;Advances in Predictive, Preventive and Personalised Medicine;2015

4. Pharmacogenomics of Central Nervous System (CNS) Drugs;Drug Development Research;2012-10-18

5. Pharmacogenomics of Alzheimer's disease;Asia-Pacific Psychiatry;2011-03